Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-250645
Filing Date
2018-08-16
Accepted
2018-08-16 16:07:05
Documents
4
Period of Report
2018-09-20
Effectiveness Date
2018-08-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d568690ddef14a.htm DEF 14A 290974
2 GRAPHIC g568690g37t13.jpg GRAPHIC 843
3 GRAPHIC g568690g78f80.jpg GRAPHIC 523
4 GRAPHIC g568690g81k76.jpg GRAPHIC 832
  Complete submission text file 0001193125-18-250645.txt   295649
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 033-80623 | Film No.: 181023412
SIC: 2835 In Vitro & In Vivo Diagnostic Substances